Rigat, B. A., Tropak, M. B., Buttner, J., Crushell, E., Benedict, D., Callahan, J. W., . . . Mahuran, D. J. (2012). Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.
Citação norma ChicagoRigat, Brigitte A., Michael B. Tropak, Justin Buttner, Ellen Crushell, Daphne Benedict, John W. Callahan, Douglas R. Martin, and Don J. Mahuran. Evaluation of N-nonyl-deoxygalactonojirimycin As a Pharmacological Chaperone for Human GM1 Gangliosidosis Leads to Identification of a Feline Model Suitable for Testing Enzyme Enhancement Therapy. 2012.
MLA citiranjeRigat, Brigitte A., et al. Evaluation of N-nonyl-deoxygalactonojirimycin As a Pharmacological Chaperone for Human GM1 Gangliosidosis Leads to Identification of a Feline Model Suitable for Testing Enzyme Enhancement Therapy. 2012.